Close

Noble Financial Keeps Agile Therapeutics (AGRX) at 'Buy'; Q2 Results Inline, Key Phase 3 Data Expected in Q4

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. SPY
4. CSX
5. UAL
6. TSLA
7. EFX
8. ORCL
9. CCI
10. INFY


Go back to Noble Financial Keeps Agile Therapeutics (AGRX) at 'Buy'; Q2 Results Inline, Key Phase 3 Data Expected in Q4

Form 10-Q AGILE THERAPEUTICS INC For: Jun 30

August 8, 2016 4:14 PM EDT

Table of Contents

 

 

... More

Form 8-K AGILE THERAPEUTICS INC For: Aug 08

August 8, 2016 4:10 PM EDT

 

 

UNITED STATES

... More